VC-backed CinCor prices IPO
CinCor Pharma, a developer of treatment for hypertension and other cardio-renal diseases, has priced its IPO of 11 million shares at a price range between $15 and $17 per share.
3 January 2022•3 mins read
CinCor Pharma, a developer of treatment for hypertension and other cardio-renal diseases, has priced its IPO of 11 million shares at a price range between $15 and $17 per share.
